[HTML][HTML] Autoimmune post-COVID vaccine syndromes: does the spectrum of autoimmune/inflammatory syndrome expand?

LJ Jara, O Vera-Lastra, N Mahroum, C Pineda… - Clinical …, 2022 - Springer
To date, around 60% of the world population has been protected by vaccines against SARS-
CoV-2, significantly reducing the devastating effect of the pandemic and restoring social …

[HTML][HTML] Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) in 2023

JWC Tervaert, M Martinez-Lavin, LJ Jara, G Halpert… - Autoimmunity …, 2023 - Elsevier
In 2011, a syndrome entitled ASIA (Autoimmune/inflammatory Syndrome Induced by
Adjuvants; Shoenfeld's syndrome) was first described. ASIA aimed to organize under a …

An update on polymyalgia rheumatica

IE Lundberg, A Sharma, C Turesson… - Journal of Internal …, 2022 - Wiley Online Library
Polymyalgia rheumatica (PMR) is the most common inflammatory rheumatic disease
affecting people older than 50 years and is 2–3 times more common in women. The most …

COVID-19 vaccination and the eye

MTM Wang, RL Niederer, CNJ McGhee… - American Journal of …, 2022 - Elsevier
Purpose To summarize the current evidence on COVID-19 vaccine-associated ocular
adverse events. Design Narrative literature review. Methods The literature search was …

[HTML][HTML] Vaccinations and autoimmune diseases

B Olivieri, C Betterle, G Zanoni - Vaccines, 2021 - mdpi.com
Vaccines represent one of the most effective measures of public health medicine, saving
countless lives and preventing lifelong disabilities. Vaccines are extremely safe, however …

Risk of giant cell arteritis and polymyalgia rheumatica following COVID-19 vaccination: a global pharmacovigilance study

C Mettler, AP Jonville-Bera, A Grandvuillemin… - …, 2022 - academic.oup.com
DEAR EDITOR, COVID-19 vaccines rely on next-generation vaccine platforms of which
safety profiles are, to date, not well characterized. Sporadic cases of GCA secondary to …

Inflammatory rheumatic diseases with onset after SARS-CoV-2 infection or COVID-19 vaccination: a report of 267 cases from the COVID-19 and ASD group

F Ursini, P Ruscitti, O Addimanda, R Foti… - RMD open, 2023 - rmdopen.bmj.com
Objectives To better define the spectrum of new-onset post-COVID-19 and post-COVID-19
vaccine inflammatory rheumatic diseases (IRD) from a large multicentric observational …

[HTML][HTML] Polymyalgia rheumatica as uncommon adverse event following immunization with COVID‐19 vaccine: A case report and review of literature

C Manzo, M Natale, A Castagna - Aging Medicine, 2021 - ncbi.nlm.nih.gov
Polymyalgia rheumatica as uncommon adverse event following immunization with COVID‐19
vaccine: A case report and review of literature - PMC Back to Top Skip to main content NIH …

Circadian clock genes as promising therapeutic targets for autoimmune diseases

K Xiang, Z Xu, YQ Hu, YS He, GC Wu, TY Li… - Autoimmunity …, 2021 - Elsevier
Circadian rhythm is a natural, endogenous process whose physiological functions are
controlled by a set of clock genes. Disturbance of the clock genes have detrimental effects …

Immune system activation in polymyalgia rheumatica: which balance between autoinflammation and autoimmunity? A systematic review

E Hysa, E Gotelli, S Sammori, MA Cimmino… - Autoimmunity …, 2022 - Elsevier
Background and aim Polymyalgia rheumatica (PMR) is an inflammatory rheumatic disease
that is common in elderly people. Its classification in the spectrum of autoinflammatory and …